PAM
PVG Asset Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $609K | Buy |
+16,069
| New | +$609K | 1.44% | 19 |
|
|
2019
Q4 | – | Sell |
-24,269
| Closed | -$1.04M | – | 75 |
|
|
2019
Q3 | $1.04M | Sell |
24,269
-1,596
| -6% | -$68.1K | 1.12% | 29 |
|
|
2019
Q2 | $1.04M | Sell |
25,865
-3,611
| -12% | -$144K | 1.09% | 29 |
|
|
2019
Q1 | $1.23M | Sell |
29,476
-124
| -0.4% | -$5.18K | 1.11% | 27 |
|
|
2018
Q4 | $1.13M | Sell |
29,600
-20,152
| -41% | -$770K | 1.11% | 34 |
|
|
2018
Q3 | $2M | Buy |
49,752
+20,058
| +68% | +$806K | 1.43% | 19 |
|
|
2018
Q2 | $1.2M | Sell |
29,694
-3,688
| -11% | -$149K | 0.71% | 47 |
|
|
2018
Q1 | $1.3M | Sell |
33,382
-187,068
| -85% | -$7.31M | 0.73% | 39 |
|
|
2017
Q4 | $7.82M | Buy |
220,450
+165,920
| +304% | +$5.89M | 3.57% | 6 |
|
|
2017
Q3 | $2.21M | Sell |
54,530
-6,251
| -10% | -$254K | 0.97% | 31 |
|
|
2017
Q2 | $2.62M | Sell |
60,781
-37,373
| -38% | -$1.61M | 0.99% | 34 |
|
|
2017
Q1 | $4.14M | Sell |
98,154
-88,399
| -47% | -$3.73M | 1.28% | 26 |
|
|
2016
Q4 | $7.18M | Buy |
186,553
+131,190
| +237% | +$5.05M | 3.02% | 7 |
|
|
2016
Q3 | $2.39M | Buy |
55,363
+1,176
| +2% | +$50.7K | 1.01% | 35 |
|
|
2016
Q2 | $2.35M | Sell |
54,187
-1,683
| -3% | -$72.9K | 0.97% | 36 |
|
|
2016
Q1 | $2.27M | Buy |
+55,870
| New | +$2.27M | 0.89% | 42 |
|